Cyclophosphamide Injection 500 mg/5 mL (100 mg/mL), Hazardous Drug, Rx Only, Sterile, 5mL Multipl...

FDA Recall #D-0651-2025 — Class II — September 5, 2025

Recall #D-0651-2025 Date: September 5, 2025 Classification: Class II Status: Ongoing

Product Description

Cyclophosphamide Injection 500 mg/5 mL (100 mg/mL), Hazardous Drug, Rx Only, Sterile, 5mL Multiple Dose Vial, Manufactured in Austria by Fareva Unterach GmbH for Sandoz Inc., Princeton, NJ 08540, Product of India, Vial NDC# 0781-3528-75, Carton NDC# 0781-3528-10.

Reason for Recall

cGMP deviations: Temperature excursion during transportation.

Recalling Firm

Sandoz Inc — Princeton, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

6 vials

Distribution

Nationwide in the USA

Code Information

Only the following 6 GTN Numbers for Lot # 110459 exp. date 02/28/2027: (01)00307813528104(21)10686040629319 (01)00307813528104(21)10687281435306 (01)00307813528104(21)10687409963168 (01)00307813528104(21)10701200331212 (01)00307813528104(21)10687325644911 (01)00307813528104(21)10687661160169

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated